With a new organizational structure meant to accelerate growth, Imperative Care is seeking to improve care even more for people with strokes and other ischemic diseases.
There is an urgent need for better stroke care. Strokes hit a new person every 40 seconds in the U.S. — and kill someone about every 3 minutes, according to the Centers for Disease Control and Prevention.
Imperative Care CEO Fred Khosravi sees the company achieving its goals through new device designs and bolder business models. He’s the keynote interview closing out the first day of our DeviceTalks West show, Oct. 18–19 in Santa Clara, California. (Register here.)
“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” Khosravi said in August. “We believe that the patient is the only constant in the chain of care from detection through treatment and recovery. Through connected innovation, we can look holistically at what the patient needs across the full continuum of care and achieve something meaningful for patients and their families.”
Under a new organization structure that the company announced in August, the entities under the Imperative Care umbrella include Imperative Care Stroke, Imperative Care Vascular, Kandu Health and Telos Health.
Other recent news includes positive data from a neurovascular outcome database evaluating its Zoom stroke solution. Just yesterday, the company reported positive new data demonstrating that the use of Zoom aspiration catheters is associated with lower procedural costs for people with acute ischemic stroke.
